<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Piracetam was applied to the treatment of 60 patients with the initial manifestations of brain blood supply failure and stage I <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> associated with <z:mpath ids='MPATH_105'>circulatory disorders</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Echopulsography of the intracranial vessels and dopplerography of the extracranial vessels of the brain were employed, changes in <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism, rheological and coagulation properties of the blood were defined </plain></SENT>
<SENT sid="2" pm="."><plain>Continuous use of piracetam per os was found to produce a number of beneficial therapeutic effects </plain></SENT>
<SENT sid="3" pm="."><plain>Some patients suffering from <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> associated with <z:mpath ids='MPATH_105'>circulatory disorders</z:mpath> showed <z:hpo ids='HP_0002315'>headache</z:hpo> enhancement after intake of 1.6 g of the drug, accompanied by a considerable increase of the amplitude of pulse fluctuations, prompting the reduction of the drug dose </plain></SENT>
<SENT sid="4" pm="."><plain>Piracetam decreased the high vascular resistance and raised the lowered volume of pulse fluctuations </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> the patients examined, aggregation of formed elements of the blood returned to <z:mpath ids='MPATH_458'>normal</z:mpath> whereas the content of atherogenic <z:chebi fb="23" ids="18059">lipids</z:chebi> in blood serum significantly dropped </plain></SENT>
</text></document>